Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to keep injured workers on the job

NCT ID NCT07037927

Recruiting now Disease control Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program called RETAIN that helps people who are injured or ill stay at work or return to work. The program assigns a case manager to coordinate care and connect workers with job support services. About 1,000 adults in Minnesota who are employed or recently unemployed due to a health issue will take part. The goal is to see if this support helps people keep their jobs and avoid long-term disability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
RETAIN Program (return-to-work case management and coordination)
What this could lead to
If successful, this program could help thousands of injured or ill workers keep their jobs and reduce long-term disability.
What could go wrong
This is a non-randomized trial, so results may be influenced by factors other than the program. It is also limited to Minnesota, so findings may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISABILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DISABILITY ILLNESS RELATED WORK INJURIES RELATED WORK

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.